InvestorsHub Logo

BottomBounce

10/31/16 8:25 AM

#1745 RE: StockDog OTC #1742

$PMCB PharmaCyte Biotech, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology, known as Cell-in-a-Box. Its Cell-in-a-Box technology would be used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, and diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of the cancer. It is also developing a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes; and examining the benefits of the Cell-in-a-Box technology to develop therapies for cancer based upon the constituents of the Cannabis plant. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was founded in 1996 and is based in Silver Spring, Maryland.

BottomBounce

10/31/16 8:41 AM

#1746 RE: StockDog OTC #1742

$VPOR Vapor Group, Inc. designs, develops, manufactures, and markets vaporizers, and e-cigarettes and accessories in the United States. It markets its products under the Vapor Group, Total Vapor, Vapor 123, and Vapor Products brands. The company sells its products through distributors and wholesalers, as well as directly to consumers through its Websites. Vapor Group, Inc. was founded in 2012 and is headquartered in Miami, Florida.